Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$2.24 - $4.18 $479,091 - $894,018
213,880 New
213,880 $580,000
Q2 2022

Aug 15, 2022

SELL
$2.85 - $7.77 $600,386 - $1.64 Million
-210,662 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$5.7 - $9.3 $1.02 Million - $1.66 Million
-178,853 Reduced 45.92%
210,662 $1.6 Million
Q4 2021

Feb 14, 2022

BUY
$8.73 - $15.27 $1.46 Million - $2.55 Million
167,138 Added 75.16%
389,515 $3.4 Million
Q3 2021

Nov 15, 2021

BUY
$13.52 - $23.95 $1.35 Million - $2.39 Million
99,967 Added 81.67%
222,377 $3.08 Million
Q2 2021

Aug 16, 2021

BUY
$22.12 - $32.06 $1.62 Million - $2.35 Million
73,206 Added 148.78%
122,410 $2.96 Million
Q1 2021

May 17, 2021

BUY
$26.12 - $52.17 $9,063 - $18,102
347 Added 0.71%
49,204 $1.58 Million
Q4 2020

Feb 16, 2021

BUY
$14.05 - $29.0 $676,605 - $1.4 Million
48,157 Added 6879.57%
48,857 $1.2 Million
Q3 2020

Nov 16, 2020

SELL
$14.17 - $19.48 $217,325 - $298,764
-15,337 Reduced 95.64%
700 $10,000
Q2 2020

Aug 14, 2020

BUY
$13.25 - $21.72 $212,490 - $348,323
16,037 New
16,037 $259,000
Q1 2020

May 15, 2020

SELL
$9.73 - $24.9 $1.01 Million - $2.58 Million
-103,525 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$14.22 - $23.38 $1.65 Million - $2.71 Million
-115,984 Reduced 52.84%
103,525 $2.18 Million
Q3 2019

Nov 14, 2019

BUY
$22.93 - $41.06 $4 Million - $7.16 Million
174,329 Added 385.85%
219,509 $5.03 Million
Q2 2019

Aug 14, 2019

BUY
$38.73 - $52.03 $1.75 Million - $2.35 Million
45,180 New
45,180 $1.82 Million
Q1 2019

May 15, 2019

SELL
$28.11 - $50.77 $286,131 - $516,787
-10,179 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$26.22 - $56.89 $266,893 - $579,083
10,179 New
10,179 $273,000

Others Institutions Holding CGC

About Canopy Growth Corp


  • Ticker CGC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 480,284,000
  • Market Cap $2.12B
  • Description
  • Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include d...
More about CGC
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.